Incidence and risk factors for low trauma fractures in men with prostate cancer

被引:21
作者
Ahlborg, Henrik G. [1 ,2 ]
Nguyen, Nguyen D. [1 ]
Center, Jacqueline R. [1 ]
Eisman, John A. [1 ,3 ]
Nguyen, Tuan V. [1 ,3 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, Sydney, NSW 2010, Australia
[2] Malmo Univ Hosp, Dept Orthopaed, Malmo, Sweden
[3] Univ New S Wales, Fac Med, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
bone mineral density; fracture; men; osteoporosis; prostate cancer;
D O I
10.1016/j.bone.2008.05.003
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Men with prostate cancer on androgen deprivation therapy (ADT) are at increased risk of bone loss. The present study sought to determine the incidence of low trauma fracture in men with prostate cancer I (PC), and to characterize the association between potential risk factors and fracture risk in these men. Methods: In the prospective, population-based Dubbo Osteoporosis Epidemiology Study, 43 men aged 60+ years reported a history of prostate cancer; among whom, 22 men received ADT, and 21 men did not. Low-trauma fractures were ascertained between 1989 and 2004. Bone mineral density at the femoral neck (FNBMD), postural instability and lifestyle factors were obtained at baseline. Results: Men with prostate cancer had significantly higher lumbar spine BMD than those without cancer (p=0.013). During the follow-up period, 15 men with prostate cancer had sustained a fracture, yielding the age-adjusted incidence of fracture among this group was 31.6 per 1000 person-years, which was greater than those without cancer (22.1 per 1000 person-years). The age-adjusted incidence of fracture was more pronounced among those with Prostate cancer on ADT (40.2 per 1000 person-years). After adjusting for age, the increase in fracture Fisk among Prostate cancer patients was associated with lower femoral neck BMD (hazard ratio [HR] per SD= 1.8, 95% CI: 1.0-3.4) and increased rate of bone loss (HR 2.3, 1.2-4.6). Conclusions: Men with prostate cancer, particularly those treated with ADT, had an increased fracture risk. Although the average BMD in men with prostate cancer Was higher than men without cancer, a low BMD prior to treatment or increased rate of bone loss after initiating ADT treatment was each a significant predictor of fracture in these. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 41 条
[1]
Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy [J].
Berruti, A ;
Dogliotti, L ;
Terrone, C ;
Cerutti, S ;
Isaia, G ;
Tarabuzzi, R ;
Reimondo, G ;
Mari, M ;
Ardissone, P ;
De Luca, S ;
Fasolis, G ;
Fontana, D ;
Rossetti, SR ;
Angeli, A .
JOURNAL OF UROLOGY, 2002, 167 (06) :2361-2367
[2]
Metabolic bone disease induced by prostate cancer: Rationale for the use of bisphosphonates [J].
Berruti, A ;
Dogliotti, L ;
Tucci, M ;
Tarabuzzi, R ;
Fontana, D ;
Angeli, A .
JOURNAL OF UROLOGY, 2001, 166 (06) :2023-2031
[3]
Chen C, 2003, CANCER EPIDEM BIOMAR, V12, P1410
[4]
COX DR, 1972, J R STAT SOC B, V34, P187
[5]
Progressive osteoporosis during androgen deprivation therapy for prostate cancer [J].
Daniell, HW ;
Dunn, SR ;
Ferguson, DW ;
Lomas, G ;
Niazi, Z ;
Stratte, PT .
JOURNAL OF UROLOGY, 2000, 163 (01) :181-186
[6]
Osteoporosis after orchiectomy for prostate cancer [J].
Daniell, HW .
JOURNAL OF UROLOGY, 1997, 157 (02) :439-444
[7]
Osteoporosis and spinal fractures in men with prostate cancer: Risk factors and effects of androgen deprivation therapy [J].
Diamond, TH ;
Bucci, J ;
Kersley, JH ;
Aslan, P ;
Lynch, WB ;
Bryant, C .
JOURNAL OF UROLOGY, 2004, 172 (02) :529-532
[8]
Prospective study of sex hormone levels and risk of prostate cancer [J].
Gann, PH ;
Hennekens, CH ;
Ma, J ;
Longcope, C ;
Stampfer, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (16) :1118-1126
[9]
GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515
[10]
Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36